SANUWAVE Health, Inc. (SNWV)
OTCMKTS · Delayed Price · Currency is USD
21.00
-1.50 (-6.67%)
Dec 31, 2024, 2:46 PM EST

SANUWAVE Health Statistics

Total Valuation

SANUWAVE Health has a market cap or net worth of 196.29 million. The enterprise value is 227.78 million.

Market Cap 196.29M
Enterprise Value 227.78M

Important Dates

The next estimated earnings date is Wednesday, March 26, 2025.

Earnings Date Mar 26, 2025
Ex-Dividend Date n/a

Share Statistics

SANUWAVE Health has 8.53 million shares outstanding. The number of shares has increased by 77.92% in one year.

Current Share Class n/a
Shares Outstanding 8.53M
Shares Change (YoY) +77.92%
Shares Change (QoQ) -13.93%
Owned by Insiders (%) 3.69%
Owned by Institutions (%) 2.97%
Float 6.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.44
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 570.60
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.32, with an EV/FCF ratio of 662.16.

EV / Earnings -585.56
EV / Sales 7.77
EV / EBITDA 46.32
EV / EBIT 57.90
EV / FCF 662.16

Financial Position

The company has a current ratio of 0.12

Current Ratio 0.12
Quick Ratio 0.07
Debt / Equity n/a
Debt / EBITDA 7.07
Debt / FCF 101.03
Interest Coverage 0.28

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 11.66%
Return on Capital (ROIC) n/a
Revenue Per Employee 945,226
Profits Per Employee -12,548
Employee Count 31
Asset Turnover 1.39
Inventory Turnover 3.09

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +370.77% in the last 52 weeks. The beta is 1.16, so SANUWAVE Health's price volatility has been higher than the market average.

Beta (5Y) 1.16
52-Week Price Change +370.77%
50-Day Moving Average 20.35
200-Day Moving Average 10.72
Relative Strength Index (RSI) 53.93
Average Volume (20 Days) 9,143

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.89

Income Statement

In the last 12 months, SANUWAVE Health had revenue of 29.30 million and -389,000 in losses. Loss per share was -0.13.

Revenue 29.30M
Gross Profit 21.34M
Operating Income 3.93M
Pretax Income -385,000
Net Income -389,000
EBITDA 4.92M
EBIT 3.93M
Loss Per Share -0.13
Full Income Statement

Balance Sheet

The company has 3.26 million in cash and 34.76 million in debt, giving a net cash position of -31.50 million or -3.69 per share.

Cash & Cash Equivalents 3.26M
Total Debt 34.76M
Net Cash -31.50M
Net Cash Per Share -3.69
Equity (Book Value) -60.26M
Book Value Per Share -19.13
Working Capital -71.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 429,000 and capital expenditures -85,000, giving a free cash flow of 344,000.

Operating Cash Flow 429,000
Capital Expenditures -85,000
Free Cash Flow 344,000
FCF Per Share 0.04
Full Cash Flow Statement

Margins

Gross margin is 72.84%, with operating and profit margins of 13.43% and -1.33%.

Gross Margin 72.84%
Operating Margin 13.43%
Pretax Margin -1.31%
Profit Margin -1.33%
EBITDA Margin 16.78%
EBIT Margin 13.43%
FCF Margin 1.17%

Dividends & Yields

SANUWAVE Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -77.92%
Shareholder Yield -77.92%
Earnings Yield -0.54%
FCF Yield 0.18%

Stock Splits

The last stock split was on October 18, 2024. It was a reverse split with a ratio of 0.0026667.

Last Split Date Oct 18, 2024
Split Type Reverse
Split Ratio 0.0026667

Scores

SANUWAVE Health has an Altman Z-Score of -17.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -17.14
Piotroski F-Score n/a